Biorasi: Faster clinical trials
Biorasi is a global, award-winning and full-service contract research organization (CRO) that delivers the speed and agility that today’s small and midsized pharmaceutical and device companies desperately need. We accelerate your clinical trials to rapid completion with our unconventional approach to clinical research.
Biorasi is faster than other CROs throughout the entire life cycle of the trial, from initial engagement to study closeout.
Enable FPI faster.
Experience the joy of streamlined start-up.
Go-live in record time.
Experience the science behind Biorasi data.
Get in step with the patient journey.
Experience our recruitment solutions.
Go-live in record time.
Experience the science behind Biorasi data.
Know sooner.
Experience rapid, reliable results.
Rare and Urgent Disease
Real solutions
Rare and Urgent Disease
Real solutions
Speed and agility are at the core of a successful rare disease clinical trial. Biorasi excels in overcoming common challenges faced during these studies, leveraging industry expertise, cutting-edge technology, and our deep commitment to rare and urgent disease clinical research.
Patient Recruitment
Rapid enrollment
Patient Recruitment
Rapid enrollment
The faster you recruit, the faster your trials finish. Biorasi enrolls your patients eight times quicker than other CROs by optimizing patient-centric strategies, deploying local and global clinical trial recruitment solutions, and customizing individual enrollment plans for rare and urgent disease.
DECENTRALIZED TRIALS
Flexible tech
DECENTRALIZED TRIALS
Flexible tech
Biorasi’s decentralized solutions empower you to adapt seamlessly to everyday challenges and unforeseen obstacles. Our complete virtual clinical trial conduct at remote or inaccessible locations, such as during lockdowns, keeps your pivotal studies moving forward. Take the risk out of your clinical studies and stay agile with our remote monitoring and remote patient solutions.
The Latest Insights From Biorasi
News
Biorasi Welcomes Nephrologist
Dr. Jamie Dwyer to Scientific Advisory Board
News
Biorasi’s Jimmy El Hokayem Appointed to Scientific Advisory Board for the Foundation for Angelman Syndrome Therapeutics
News
Biorasi Welcomes Hematologist Dr. Robert S. Negrin to Scientific Advisory Board
Article
Keep it Simple: The Top 5 Steps for Successful Protocol Design
Join Us at these upcoming events
Sorry, no resources found.